New hope for advanced liver cancer: immunotherapy cocktails under study

NCT ID NCT04524871

Recruiting now Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This clinical trial is testing several combinations of immunotherapy drugs to see if they can shrink or control advanced liver cancer. The study is for people with a type of liver cancer called hepatocellular carcinoma (HCC) that has spread or cannot be removed by surgery. Participants will be randomly assigned to receive one of the treatment combinations, and the study will monitor how well the cancer responds and how long it stays under control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma liver cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED LIVER CANCERS

Contacts and locations

Locations

Asan Medical Center
RECRUITING

Seoul, 5505, South Korea
Auckland City Hospital
RECRUITING

Auckland, 1023, New Zealand
Beijing Cancer Hospital
ACTIVE_NOT_RECRUITING

Beijing, 100036, China
CHA Bundang Medical Center
ACTIVE_NOT_RECRUITING

Gyeonggi-do, 13496, South Korea
CHU Hôpitaux de Marseille
RECRUITING

Marseille, France
Centre Eugène Marquis
ACTIVE_NOT_RECRUITING

Rennes, 35042, France
Centre Georges Francois Leclerc
ACTIVE_NOT_RECRUITING

Dijon, 21079, France
Cherry Creek Medical Center
RECRUITING

Aurora, Colorado, 80045, United States
City of Hope
RECRUITING

Duarte, California, 91010, United States
Davidof Center - Rabin Medical Center
RECRUITING

Petah Tikva, 4941492, Israel
Georgetown University Medical Center
RECRUITING

Washington D.C., District of Columbia, 20007, United States
Gustave Roussy
ACTIVE_NOT_RECRUITING

Villejuif, 94800, France
Hadassah University Medical Center
RECRUITING

Jerusalem, Israel
National Cheng Kung University Hospital
RECRUITING

Tainan, 70457, Taiwan
National Taiwan University Hospital
RECRUITING

Taipei, 10002, Taiwan
Oregon Health & Science University
RECRUITING

Portland, Oregon, 97239, United States
Parkland Health & Hospital System
RECRUITING

Dallas, Texas, 75235, United States
Rambam Medical Center
RECRUITING

Haifa, 3109601, Israel
Samsung Medical Center
RECRUITING

Seoul, 06351, South Korea
Sarah Cannon Research Institute / Tennessee Oncology
COMPLETED

Nashville, Tennessee, 37203, United States
Seoul National University Hospital
WITHDRAWN

Seoul, 03080, South Korea
Smilow Cancer Hospital at Yale New Haven
RECRUITING

New Haven, Connecticut, 06510, United States
Sourasky Medical Centre
RECRUITING

Tel Aviv, 64239, Israel
The University of Texas Southwestern Medical Center at Dallas
RECRUITING

Dallas, Texas, 75390, United States
UC Irvine Medical Center
RECRUITING

Costa Mesa, California, 92627, United States
UC Irvine Medical Center
COMPLETED

Orange, California, 92868, United States
UCHealth Cancer Center Pharmacy - Highlands Ranch Hospital
RECRUITING

Highlands Ranch, Colorado, 80129-6694, United States
UCLA Center for East
RECRUITING

Santa Monica, California, 90404, United States
University of California San Diego Medical Center
RECRUITING

San Diego, California, 92103, United States
University of California San Francisco Cancer Center
RECRUITING

San Francisco, California, 94115, United States
University of Colorado Hospital - Anschutz Cancer Pavilion
RECRUITING

Aurora, Colorado, 80045, United States
University of Kentucky - Markey Cancer Center
RECRUITING

Lexington, Kentucky, 40536-7001, United States
Zhongshan Hospital Fudan University
COMPLETED

Shanghai, 200032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.